High probability of disease in angina pectoris patients: Is clinical estimation reliable?

Canadian Journal of Cardiology

Volumn 23, Issue 8, 2007, Pages 641-647

  Høilund Carlsen, Poul F ^a   Johansen, Allan ^a   Vach, Werner ^b   Christensen, Henrik Wulff ^c   Møldrup, Mette ^a   Haghfelt, Torben ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c NORDIC INSTITUTE OF CHIROPRACTIC AND CLINICAL BIOMECHANICS   (Denmark)

Author keywords

Angina; Angiography; Coronary artery disease; Diagnosis; Ischemia; Perfusion; Scintigraphy

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LONG ACTING DRUG; NITRATE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREDICTION; PROBABILITY; PROSPECTIVE STUDY; RELIABILITY; SEX DIFFERENCE;

EID: 34547495036     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(07)70226-X     Document Type: Article

References (41)

1. Canadian Cardiovascular Society 1997 Consensus Conference on the Evaluation and Management of Chronic Ischemic Heart Disease. Can J Cardiol 1998;14(Suppl C):1C-23C.
2. Brindis RG, Douglas PS, Hendel RC, et al; American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group; American Society of Nuclear Cardiology; American Heart Association. ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): A report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol 2005;46:1587-605. (Erratum in 2005;46:2148-50).
3. Fox K, Garcia MA, Ardissino D, et al; Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: Executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-81.
4. Hachamovitch R, Berman DS. The use of nuclear cardiology in clinical decision making. Semin Nucl Med 2005;35:62-72.
5. Klocke FJ, Baird MG, Lorell BH, et al; American College of Cardiology; American Heart Association; American Society for Nuclear Cardiology. ACC/ AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/ ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-33.
6. National Institute for Clinical Excellence. TA73 Angina and myocardial infarction - myocardial perfusion scintigraphy: Guidance. (Version current at May 15, 2007).
7. Reyes E, Underwood SR. Myocardial perfusion scintigraphy: An important step between clinical assessment and coronary angiography in patients with stable chest pain. Eur Heart J 2006;27:3-4.
8. Gobel FL, Stewart WJ, Campeau L, et al. Safety of coronary arteriography in clinically stable patients following coronary bypass surgery. Post CABG Clinical Trial Investigators. Cathet Cardiovasc Diagn 1998;45:376-81.
9. Busing KA, Schulte-Sasse C, Fluchter S, et al. Cerebral infarction: Incidence and risk factors after diagnostic and interventional cardiac catheterization - prospective evaluation at diffusion-weighted MR imaging. Radiology 2005;235:177-83.
10. Diamond GA. A clinically relevant classification of chest discomfort. J Am Coll Cardiol 1983;1:574-5.
11. Campeau L. Letter: Grading of angina pectoris. Circulation 1976;54:522-3.
12. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.
13. Shaw LJ, Hachamovitch R, Iskandrian AE. Treadmill test scores: Attributes and limitations. J Nucl Cardiol 1997;4:74-8.
14. Pryor DB, Harrell FE, Lee KL, Califf RM, Rosati RA. Estimating the likelihood of significant coronary artery disease. Am J Med 1983;75:771-80.
15. Diamond GA, Staniloff HM, Forrester JS, Pollock BH, Swan HJ. Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol 1983;1:444-55.
16. Høilund-Carlsen PF, Johansen A, Christensen HW, et al. Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: Observational study without post-test referral bias. Eur Heart J 2006;27:29-34.
17. Christensen HW, Haghfelt T, Vach W, Johansen A, Høilund-Carlsen PF. Observer reproducibility and validity of systems for clinical classification of angina pectoris: Comparison with radionuclide imaging and coronary angiography. Clin Physiol Funct Imaging 2006;26:26-31.
18. Berman DS, Kiat H, Friedman JD, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: A clinical validation study. J Am Coll Cardiol 1993;22:1455-64.
19. Johansen A, Høilund-Carlsen PF, Christensen HW, et al. Observer variability in the evaluation of dual-isotope Tl-201/Tc-99m sestamibi rest/stress myocardial perfusion SPECT in men and women with known or suspected stable angina pectoris. J Nucl Cardiol 2004;11:710-8.
20. Saunamäki K, Egstrup K, Mickley H, Nielsen JR, Schnohr P, Thomassen AR. [Guidelines for Exercise-Testing in Ischemic Heart Disease.] Copenhagen: Danish Society of Cardiology, 1995.
21. Johansen A, Høilund-Carlsen PF, Christensen HW, et al. Diagnostic accuracy of myocardial perfusion imaging in a study population without post-test referral bias. J Nucl Cardiol 2005;12:530-7.
22. Høilund-Carlsen PF, Johansen A, Christensen HW, et al. Usefulness of the exercise electrocardiogram in diagnosing ischemic or coronary heart disease in patients with chest pain. Am J Cardiol 2005;95:96-9.
23. Gibbons RJ, Abrams J, Chatterjee K, et al; American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: A report of die American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-68.
24. Gobel FL, Stewart WJ, Campeau L, et al. Safety of coronary arteriography in clinically stable patients following coronary bypass surgery. Post CABG Clinical Trial Investigators. Cathet Cardiovasc Diagn 1998;45:376-81.
25. Pell JP, Walsh D, Norrie J, et al. Outcomes following coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in the stent era: A prospective study of all 9890 consecutive patients operated on in Scotland over a two year period. Heart 2001;85:662-6.
26. Krone RJ, Shaw RE, Klein LW, et al; ACC-National Cardiovascular Data Registry. Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current "stent era" of coronary interventions (from the ACC-National Cardiovascular Data Registry). Am J Cardiol 2003;92:389-94.
27. Pryor, DB, Shaw L, McCants CB, et al. Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med 1993; 118:81-90.
28. Morise AP, Detrano R, Bobbio M, Diamond GA. Development and validation of a logistic regression-derived algorithm for estimating the incremental probability of coronary artery disease before and after exercise testing. J Am Coll Cardiol 1992;20:1187-96.
29. Sox HC Jr, Hickam DH, Marton KI, et al. Using the patient's history to estimate the probability of coronary artery disease: A comparison of primary care and referral practices. Am J Med 1990;89:7-14. (Erratum in 1990;89:550).
30. Gimelli A, Schneider-Eicke J, Neglia D, et al. Homogeneously reduced versus regionally impaired myocardial blood flow in hypertensive patients: Two different patterns of myocardial perfusion associated with degree of hypertrophy. J Am Coll Cardiol 1998;31:366-73.
31. Lee KH, Jang HJ, Lee SC, et al. Myocardial thallium defects in apical hypertrophic cardiomyopathy are associated with a benign prognosis. Thallium defects in apical hypertrophy. Int J Cardiovasc Imagaing 2003;19:381-8.
32. Elhendy A, van Domburg RT, Sozzi FB, Poldermans D, Bax JJ, Roelandt JR. Impact of hypertension on the accuracy of exercise stress myocardial perfusion imaging for the diagnosis of coronary artery disease. Heart 2001;85:655-61.
33. Feit F, Brooks MM, Sopko G, et al. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: Comparison with the randomized trial. BARI Investigators. Circulation 2000;101:2795-802.
34. Henderson RA, Pocock SJ, Clayton TC, et al; Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants. Seven-year outcome in the RITA-2 trial: Coronary angioplasty versus medical therapy. J Am Coll Cardiol 2003;42:1161-70.
35. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997;18:1231-48.
36. Kesteloot H. All-cause and cardiovascular mortality worldwide: Lessons from geopathology. J Cardiol 2001;37(Suppl 1):1-14.
37. Kesteloot H, Sans S, Kromhout D. Evolution of all-causes and cardiovascular mortality in the age-group 75-84 years in Europe during the period 1970-1996; a comparison with worldwide changes. Eur Heart J 2002;23:384-98.
38. Thompson CR, Humphries KH, Gao M, et al; Canadian Cardiovascular Outcomes Research Team. Revascularization use and survival outcomes after cardiac catheterization in British Columbia and Alberta. Can J Cardiol 2004;20:1417-23.
39. Shaw LJ, Hachamovitch R, Berman DS, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: An observational assessment of the value of precátheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol 1999;33:661-9.
40. Fearon WF, Gauri AJ, Myers J, Raxwal VK, Atwood JE, Froelicher VF. A comparison of treadmill scores to diagnose coronary artery disease. Clin Cardiol 2002;25:117-22.
41. Hemingway H, Fitzpatrick NK, Gnani S, et al. Prospective validity of measuring angina severity with Canadian Cardiovascular Society class: The ACRE study. Can J Cardiol 2004;20:305-9.